Kai Johnson
Physician · Ohio State University College of Medicine
Credentials: · · · · ·
History
2022–Present

- 2017–2020
Internal Medicine
Research
Emerging strategies in targeting tumor-resident myeloid cells for cancer immunotherapy
Review · Journal of Hematology & Oncology · 2022 · Co-first of 4 authors · 111 citations
European Archives of Oto-Rhino-Laryngology · 2017 · 23 citations
Analytica Chimica Acta · 2012 · First of 3 authors · 21 citations

16 papers

15 papers

13 papers

12 papers
- AD
11 papers

10 papers

9 papers

9 papers
Clinical trials
- 2010–2026
Veliparib and Carboplatin in Treating Patients With HER2-Negative Metastatic Breast Cancer
Principal investigator · Active not recruiting · Phase 1
National Cancer Institute (NCI)
- 2023–2027
Site PI · Recruiting · Phase 1
National Cancer Institute (NCI)
- 2021–2026
Site PI · Recruiting · Phase 2
National Cancer Institute (NCI)
